AAAAAA

   
Results: 1-25 | 26-39 |
Results: 26-39/39
Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations
Authors: von Moltke, LL Greenblatt, DJ Granda, BW Duan, SX Grassi, JM Venkatakrishnan, K Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations, BR J CL PH, 48(1), 1999, pp. 89-97
Human cytochromes mediating sertraline biotransformation: Seeking attribution
Authors: Greenblatt, DJ von Moltke, LL Hermatz, JS Shader, RI
Citation: Dj. Greenblatt et al., Human cytochromes mediating sertraline biotransformation: Seeking attribution, J CL PSYCH, 19(6), 1999, pp. 489-493
Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: The clinical dilemma of concurrent inhibition and induction
Authors: Greenblatt, DJ von Moltke, LL Daily, JP Harmatz, JS Shader, RI
Citation: Dj. Greenblatt et al., Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: The clinical dilemma of concurrent inhibition and induction, J CL PSYCH, 19(4), 1999, pp. 293-296
Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast
Authors: Shader, RI Granda, BW von Moltke, LL Giancarlo, GM Greenblatt, DJ
Citation: Ri. Shader et al., Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast, BIOPHARM DR, 20(8), 1999, pp. 385-388
Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): Implications for interactions with enzyme-inducing drugs (vol 39, pg 567, 1999)
Authors: Venkatakrishnan, K von Moltke, LL Greenblatt, DJ
Citation: K. Venkatakrishnan et al., Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): Implications for interactions with enzyme-inducing drugs (vol 39, pg 567, 1999), J CLIN PHAR, 39(8), 1999, pp. 866-866
Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2DG (high affinity) and CYP3A4 (low affinity): Implications for interactions with enzyme-inducing drugs
Authors: Venkatakrishnan, K von Moltke, LL Greenblatt, DJ
Citation: K. Venkatakrishnan et al., Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2DG (high affinity) and CYP3A4 (low affinity): Implications for interactions with enzyme-inducing drugs, J CLIN PHAR, 39(6), 1999, pp. 567-577
CYP2C9 is a principal low-affinity phenacetin O-deethylase: Fluvoxamine isnot a specific CYP1A2 inhibitor.
Authors: Venkatakrishnan, K von Moltke, LL Greenblatt, DJ
Citation: K. Venkatakrishnan et al., CYP2C9 is a principal low-affinity phenacetin O-deethylase: Fluvoxamine isnot a specific CYP1A2 inhibitor., DRUG META D, 27(12), 1999, pp. 1519-1520
Differentiation of intestinal and hepatic cytochrome P450 3A activity withuse of midazolam as an in vivo probe: Effect of ketoconazole
Authors: Tsunoda, SM Velez, RL von Moltke, LL Greenblatt, DJ
Citation: Sm. Tsunoda et al., Differentiation of intestinal and hepatic cytochrome P450 3A activity withuse of midazolam as an in vivo probe: Effect of ketoconazole, CLIN PHARM, 66(5), 1999, pp. 461-471
Citalopram and desmethylcitalopram in vitro: Human cytochromes mediating transformation, and cytochrome inhibitory effects
Authors: von Moltke, LL Greenblatt, DJ Grassi, JM Granda, BW Venkatakrishnan, K Duan, SX Fogelman, SM Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Citalopram and desmethylcitalopram in vitro: Human cytochromes mediating transformation, and cytochrome inhibitory effects, BIOL PSYCHI, 46(6), 1999, pp. 839-849
Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes
Authors: Perloff, MD von Moltke, LL Cotreau, MM Greenblatt, DJ
Citation: Md. Perloff et al., Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes, BIOCH PHARM, 57(11), 1999, pp. 1227-1232
Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects
Authors: von Moltke, LL Greenblatt, DJ Grassi, JM Granda, BW Fogelman, SM Harmatz, JS Kramer, SJ Fabre, LF Shader, RI
Citation: Ll. Von Moltke et al., Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects, PSYCHOPHAR, 140(3), 1998, pp. 293-299
Analysis of ritonavir in plasma/serum and tissues by high-performance liquid chromatography
Authors: Granda, BW Giancarlo, GM von Moltke, LL Greenblatt, DJ
Citation: Bw. Granda et al., Analysis of ritonavir in plasma/serum and tissues by high-performance liquid chromatography, J PHARM TOX, 40(4), 1998, pp. 235-239
Human cytochromes P450 mediating phenacetin O-deethylation in vitro: Validation of the high affinity component as an index of CYP1A2 activity
Authors: Venkatakrishnan, K von Moltke, LL Greenblatt, DJ
Citation: K. Venkatakrishnan et al., Human cytochromes P450 mediating phenacetin O-deethylation in vitro: Validation of the high affinity component as an index of CYP1A2 activity, J PHARM SCI, 87(12), 1998, pp. 1502-1507
Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole
Authors: Greenblatt, DJ von Moltke, LL Harmatz, JS Mertzanis, P Graf, JA Durol, ALB Counihan, M Roth-Schechter, B Shader, RI
Citation: Dj. Greenblatt et al., Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole, CLIN PHARM, 64(6), 1998, pp. 661-671
Risultati: 1-25 | 26-39 |